Coverage
-
October 18, 2023
A Virginia federal judge has ruled that a whistleblower has plausibly alleged that drugmaker Indivior knowingly violated the False Claims Act by concealing commercial discounts to limit rebates owed to Medicaid and invited another round of claims to fix issues in the complaint.
2 other articles on this case.
View all »